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The complex regulatory interactions among T lymphocytes initiating, amplifying, 
and suppressing  various effector-immune reactions have recently become the subject 
of intense investigation. We recently reported on a T cell participating in suppressing 
the delayed-type hypersensitivity (DTH) 1 response  to the haptenic determinant 4- 
hydroxy-3-nitrophenyl acetyl (NP)  (1). We now report on a  second population of 
suppressor  T cells capable of modulating the effector phase of the NP-specific  DTH 
response. 
NP derivatized syngeneic spleen cells given intravenously induce a population of T 
lymphocytes that, when administered to animals before sensitization with NP conju- 
gated to bovine gamma globulin (BGG) (NP-BGG), would suppress NP-specific DTH 
responses elicited with NP conjugated to bovine serum albumin (BSA) (NP-BSA),  a 
heterologous  carrier.  The fine specificity of these inducer-phase suppressor  cells was 
similar to  that  of anti-NP  antibodies.  Thus,  these  inducer-phase suppressor  cells 
adhered  to  NP-coated  dishes.  In  addition, in  strains  of mice  bearing  the  Igh-1 b 
allotype, the primary anti-NP antibody has a higher affinity for the 5-iodo derivative 
of NP  (NIP)  than  the  original  immunizing hapten  (2). This  property,  termed 
heteroclicity, was found to be demonstrable in the population of NP suppressor  cells, 
i.e.,  NP-induced suppressor  T  cells  would suppress  specifically  NIP-BGG-primed, 
NIP-specific  DTH responses in the appropriate strains.  The genetic mapping of this 
particular reactivity demonstrated that the Igh-V gene responsible  for heteroclitic 
idiotypic antibody was closely linked to the gene controlling the NP-induced sup- 
pressor  cell specificity.  In addition, NP-induced suppressor  T  cells of Igh-1 b origin 
were specifically lysed by treatment with a guinea pig anti-NP  b idiotype and comple- 
ment,  again  demonstrating the  expression  of Igh-V-gene  products  in  NP-specific 
suppressor T lymphocytes. In our previous experiments, the NP-specific suppressor  T 
cells were adoptively transferred at the time of immunization and were,  therefore, 
operationally considered afferent suppressor  T cells. 
* Supported by National Institutes of Health grants AI-00152 and AI-14732,  and  National Science 
Foundation grant PCM 77-22422. 
1Abbreviations  used  in  this  paper:  BGG,  bovine gamma  globulin;  BSA,  bovine serum  albumin; CFA, 
complete Freund's adjuvant; DTH, delayed-type hypersensitivity; GAT, poly(L-glu,  L-ala, L-tyr);  MEM, 
Eagle's minimum essential medium; MHC, major histocompatibility complex; NIP, 5-iodo derivative of 4- 
hydroxy-3-nitrophenyl acetyl; NP, 4-hydroxy-3-nitrophenyl acetyl; NP-BGG, NP conjugated to BGG; NP- 
BSA, NP conjugated to BSA; NP-SC, NP specific suppressor cells; PBS, phosphate-buffered saline; RAMIg, 
rabbit anti-mouse Is; T., suppressor T cell(s). 
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In an effort to further investigate the mechanism by which NP-specific suppression 
operates, cells from NP-suppressed mice were transferred to already primed recipients 
at various times. When this suppressor spleen cell population was transferred to mice 
primed at the time of DTH challenge, suppression was still demonstrable. The nature 
of this efferent suppression and the differential properties of these so-called effector- 
phase suppressors are the subject of this report. 
Materials and Methods 
Mice.  All mice were either purchased from The Jackson Laboratory, Bar Harbor, Maine, 
or were bred in the animal facilities of the Harvard Medical School (Boston, Mass.).  Mice were 
used at 2-10 mo of age,  and were  maintained on laboratory chow and acidified, chlorinated 
water ad libitum. The B 10.AQR(N12) mice were derived from breeding pairs provided by Dr. 
J. Forman, Southwestern Medical School,  Dallas, Tex. 
Antigens.  BSA and BGG were purchased from Sigma Chemical Co., St. Louis, Mo. NP-O- 
succinimide and NIP-O-succinimide were  purchased from Biosearch,  San Rafael, Calif. The 
preparation of NP- and NIP-conjugated proteins has been previously described (1,  3).  The 
molar conjugation ratio of haptenic groups used in this work was NP17-BGG, NIP18-BGG,, 
NPal-BSA,  and NIPg-BSA. The random synthetic terpolymer poly(L-glu,  L-ala, L-tyr)  (GAT) 
with  an  average  40,000  tool  wt  was  custom  synthesized by  Vega-Fox  Biochemicals Div., 
Newbery Energy Corp., Tucson, Ariz. 
Haptenated Cell Preparation.  Single cell suspensions of spleen cells were prepared in Eagle's 
minimum essential medium (MEM) that contained 0.5% heparin. The suspension was pelleted 
and treated  with Tris-NH4CI to  lyse erythrocytes.  After two  washes,  the  spleen cells  were 
resuspended in pH  7.6 phosphate-buffered saline (PBS)  at  108 cells/ml. 25/~1 of a  24 mg/ml 
solution of NP-O-succinimide in  dimethylsulfoxide was  added  per  milliliter of cells.  After 
allowing the reaction to proceed for 3 min at room temperature, 10-30 ml of cold, pH 7.4 PBS 
that  contained  1.2  mg/ml  glycyl-glycine was  added  to  stop  the  reaction.  The  cells  were 
extensively washed in MEM that contained 0.5% heparin before use. 
Immunization.  Experimental animals were primed with NP-BGG, NIP-BGG, or GAT emul- 
sified in complete Freund's adjuvant (CFA) (Difco Laboratories, Detroit, Mich.) that contained 
2 mg/ml Mycobacterium butyricum, so that the final concentration of antigen was 500 #g/ml in the 
CFA emulsion. 3 d before antigen priming, animals were pretreated with 20 mg/kg cyclophos- 
phamide (Mead, Johnson & Co.,  Evansville, Ind.) in 0.2 ml PBS injected intraperitoneally. A 
total of 0.2 ml antigen emulsion was injected subcutaneously, divided between two sites on the 
dorsal flanks. 
DTH Response.  6 d  after immunization, mice were challenged for the DTH response by 
injecting 25 p.1 of 1 mg/ml of NP-BSA, NIP-BSA, or GAT in PBS into the left footpad with a 
27-gauge  needle.  Footpad  swelling was  measured  24  h  after  challenge with  an  engineer's 
micrometer (Schlesinger For Tools Ltd.,  Brooklyn, N.  Y.).  Swelling was  determined as  the 
difference,  in  units of  10  -4  in.,  between  the  left  footpad  thickness  and  the  right  footpad 
thickness. All animals were measured by two independent observers,  whose measurements were 
then averaged. The responses thus elicited have been previously demonstrated to be a classical 
T cell-mediated DTH reaction by the following criteria: (a) kinetically the reaction reached a 
peak at  20-36 h after challenge; (b) T  cells were  required to transfer this reactivity to naive 
recipients; and (c) major histocompatibility complex (MHC) identity at the I-A subregion was 
necessary for transfer of reactivity (3). 
Antisera.  Rabbit anti-mouse Ig (RAMIg) was  prepared as follows:  After several  immuni- 
zations of a  rabbit with  purified normal mouse Ig,  the  rabbit antisera was  passed  over an 
immunoadsorbent that was prepared by coupling a 40% saturated ammonium sulfate precipi- 
tate  of normal  mouse serum  to  Sepharose  4B  (Pharmacia  Fine Chemicals  Inc.,  Uppsala, 
Sweden). The RAMIg was eluted from the column with 0.1 M glycine-HC1 solution at pH 2.8, 
neutralized in 2 M Tris buffer at pH 7.9, dialyzed against PBS, and adjusted to a final protein 
concentration of 1 mg/ml. 
Guinea pig anti-NPb anti-idiotypic antisera were  prepared with affinity-purified B6 anti- 
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NP-BGG in alum with 0.1  ml  pertussis vaccine  (U.  S.  Department  of Public Health, Ann 
Arbor, Mich.). The antibodies were purified by precipitation with 45% saturated ammonium 
sulfate followed by affinity purification on an NP-BSA-coupled Sepharose 4B immunoadsorb- 
ent. Specific antibody was eluted from the column by washing the column with a 0.03 M  NIP- 
caproate (Biosearch) in PBS solution. The eluate was extensively dialyzed in PBS. The eluate 
from this column contained )~x-light chain and #-, yl-, and small amounts of y~-heavy chains 
as detected by radioimmunodiffusion (4). Furthermore, isoelectric focusing of a sample of the 
radioiodinated purified Ig in  a  pH  3-10  range  polyacrylamide gel  revealed a  remarkably 
restricted spectrotype. Guinea pigs were immunized biweekly with 200 pg of purified C57BL/ 
6 anti-NP antibodies in CFA. 2 wk after the third injection, the animals were bled. The antisera 
were adsorbed on  NP conjugated to the synthetic polymer of L-glutamic acid and  L-lysine, 
MOPC  104E  (g- and "/1-heavy chains), and normal mouse serum immunoadsorbents prepared 
by glutaraldehyde cross-linking. MOPC  104E specifically purified antibody was the kind girl 
of Dr. Abul Abbas (Dept. of Pathology, Harvard Medical School). These gels were prepared 
according to the procedure of Avrameas and Ternynck (5).  After exhaustive adsorptions on 
these gels, the specificity of this reagent was verified with an  inhibition of idiotype binding 
assay, according to the method ofJu et al. (6). 30 pl of normal mouse sera, MOPC 104E ascites, 
5 pl A/J anti-NP sera, and  1.25 ×  10  -4 M  DNP-caproate did not  inhibit idiotype binding. 
However,  1 #1 of primary B6 anti-NP sera, 4.25  ×  10  -6  M  NP-caproate or 2.0  ×  10  -6 NIP- 
caproate could significantly inhibit the idiotype binding. Thus,  the anti-idiotypic antiserum 
used detects combining site determinants as previously described by other groups (7, 8). 
Cell Fractionation.  T  cells were purified according to Mage et al.  (9).  5  ml of a  1 mg/ml 
solution of purified  RAMIg was  added to  100-  ×  15-mm  polystyrene Petri  plates  (Falcon 
Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.) and  incubated for  1 h  at room 
temperature. Unbound antibody was removed, and the plates were then washed extensively in 
PBS that contained 5% fetal calf serum. Spleen cells, previously treated for 3 min at 37°C with 
Tris-NH4C1 to lyse erythrocytes, were resuspended at a concentration of 1.2 ×  107 cells/ml. 6 
ml  of cells was  added  to  the  antibody-coated plates and  incubated  for  1 h  at  4°C.  The 
nonadherent T  cell population was recovered by gentle swirling. 
Antisera Treatments.  Whole spleen lymphocyte populations of SJL strain mice were treated 
with anti-idiotypic antiserum and complement. A maximum of 3 ×  10  a cells were pelleted in 
a  17  ×  100-ram  plastic  tube  (Falcon  Labware,  Div.  of  Becton,  Dickinson  &  Co.),  and 
resuspended in 0.5 ml of unabsorbed anti-idiotypic antiserum. The suspension was incubated 
at  room  temperature  for  30  rain.  The  antisera  was  then  washed  out,  and  the  cells were 
resuspended in  1.5  ml of prescreened low-toxicity rabbit complement. This suspension was 
incubated at 37°C  for 45 min, the cells then washed three times, counted, and transferred to 
the appropriate recipients. Anti-Thy-1.2 treatments were performed as detailed elsewhere (3). 
Results 
Cellular Requirement for Transfer of Effector-Phase Suppression.  To  induce NP-specific 
suppressor cells, a suspension of erythrocyte-free spleen cells was derivatized with NP- 
O-succinimide. 2  ×  107  NP-derivatized spleen cells were  injected intravenously into 
syngeneic mice. After 7 d, these mice were sacrificed, and their spleen cells (suppressor 
cells) were transferred to syngeneic recipients that were previously cyclophosphamide 
treated and primed. These recipients had been pretreated with 20 mg/kg cyclophos- 
phamide 3 d  before immunization with  100 pg NP-BGG in CFA. 6  d  after NP-BGG 
priming, the animals received 4  ×  10  v control or suppressor spleen cells (NP-SC).  2- 
4 h  after transfer, the mice were challenged by injection of 25 #g NP-BSA in 25 #1 of 
PBS  into  the  left  footpad.  The  DTH  response  was  measured  as  the  increment  of 
footpad swelling 24 h  after challenge of the left foot as compared with the uninjected 
right foot. 
Table I  indicates that SJL and C57BL/6  mice, when given spleen cells on the day 
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TABLE I 
T Lymphocytes Mediate Effector-Phase Suppression* 
Strain  Immunogen  Cells transferred  NP DTH response 
SJL 
C57BL/6 
NP-BGG  4 X  10  7 control  45.7 + 2.0 
4 ×  107 NP-SC:~  13.8 _  2.5§ 
4 ×  10  7 NP-SC + NMS + C  7.9 + 3.0 
4 ×  10  7 NP-SC + anti-Thy + C  38.6 + 2.3§ 
CFA  None  5.5 +  1.6 
NP-BGG  4 ×  10  7 control  65.4 +  1.2 
4 ×  107 NP-SC  24.1 + 2.8§ 
12 ×  106 NP-Ts  27.6 --- 3.4§ 
6 ×  106 NP-Ts  44.6 + 6.9 
CFA  None  13.4 + 2.0 
* Groups of four to five mice were pretreated  with 20 mg/kg cyclophosphamide 3 d before priming with 
100 ug NP-BGG in 200 #1 of CFA, that was administered in divided doses subcutaneously in both flanks. 
6 d later, groups of mice received the indicated cell populaltions intravenously. On the same day as the 
cell transfer, the experimental animals were challenged with 25 #g of NP-BSA in 25 #1 of PBS in the left 
footpad, to  determine  an  NP-specific DTH  response. The  DTH  response was  measured 24  h  after 
challenge and was determined as the net footpad swelling elicited by the injected compound, in units of 
10  -4 in. 
:~ NP-SC are spleen cells from mice receiving 2 ×  l0  7 NP-derivatized syngeneic spleen cells 7 d before use 
(Materials and Methods). NMS, normal mouse serum; C, complement. 
§ P < 0.05 as compared with the appropriate control group. 
were  unable  to  mount  a  strong  NP-specific  DTH  response.  Treatment  of NP-SC 
populations  with anti-Thy-l.2 antiserum  plus complement  abrogated  the  ability of 
the  cells to  transfer  suppression,  which  indicated  that  T  cells are  necessary  for  the 
transfer of this effector-phase suppression.  To determine that T  cells alone were able 
to transfer the suppression, T  cells were purified from NP-suppressor cell populations 
by negative selection with RAMIg-coated Petri dishes. These cells contained <5% Ig- 
positive cells by immunofluorescence. Recovery was ~25%. Either 12 ×  106 or 6 ×  106 
of this enriched T  cell population was then transferred to primed mice on the day of 
challenge.  As  shown  in  Table  I,  12  ×  106  purified  suppressor  T  cells  (T~)  were 
sufficient to mediate nonresponsiveness. These two experiments demonstrate  that  T 
cells are both necessary and sufficient to transfer the observed suppression.  Because of 
the ability of these cells to acutely suppress an already primed response, this population 
of T  cells was termed effector suppressor cells. 
Specificity of NP-induced Effector Suppressor Cells in  C57BL/6  Mice.  C57BL/6  mice 
were primed with NP-BGG, NIP-BGG, or a  completely unrelated  synthetic terpoly- 
mer, GAT. 6 d  after priming, groups of mice received 4  ×  107 control or NP-induced 
effector suppressor  cells.  As  indicated  in  Table  II,  the  suppressor  cell  population, 
although efficiently suppressing the NP-specific DTH  response,  had  no effect on  the 
GAT-specific DTH  response. 
Because it  had  been  previously demonstrated  that  NP-induced suppressor  T  cells 
of C57BL/6 origin, when given to mice on the day of priming, could also suppress the 
NIP-specific DTH response (1), the effect of NP-induced effector suppressors on NIP- 
specific  DTH  responses  was  examined.  As  seen  in  Table  II,  NP-induced  effector 
suppressor cells were marginally suppressive on NIP-specific responses. The magnitude 
of the suppression was ~30% (P =  0.04). This small degree of NIP-specific suppression 
has been a  consistent  finding in a  number of other experiments, in which the degree 
of suppression  ranged from 5 to 40%. JUDAH Z. WEINBERGER, BARUJ BENACERRAF, AND MARTIN E.  DORF 
TABLE II 
Specificity of NP-induced Effector Suppressor Cells in C57BL/6 Mice* 
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Immunogen  Challenge 
Cells transferred 
Control  NP-SC 
NP-BGG  NP-BSA  49.8 4- 3.8  13.1 4- 2.2:[: 
CFA  NP-BSA  7.2 4- 2.8 
NIP-BGG  NIP-BSA  51.2 4- 4.5  36.1 4- 8.1:~ 
CFA  NIP-BSA  6.3 4- 3.0 
GAT  GAT  66.1 4- 8.5  75.6 4- 9.5 
CFA  CAT  29.5 4- 7.2 
* See Table I. 
:~ P < 0.05 as compared with the appropriate control group. 
TABLE III 
Anti-Idiotype Treatment of Inducer and Effector Suppressor Populations in SJL Mice* 
Immunogen  Cells transferred 
Time of cell transfer 
Day 0  Day 6 
NP-BGG  Control  46.3 4- 4.9  46.3 4- 4.4 
NP-SC:]:  5.9 4- 3.8§  16.7 4- 3.3§ 
NP-SC + NGPS + CI[  9.8 4- 3.4  18.9 4- 4.4 
NP-SC + anti-NP b + C  36.2 4- 3.4§  16.1 4- 7.5 
CFA  --  3.9 4- 1.2  6.2 4- 4.9 
* 4 ×  107 splenic NP suppressor cells were given each recipient. These cells or control SC 
were transferred to mice either before immunization with NP-BGG (Day 0), or 6 d after 
immunization with the antigen (Day 6). On day 6, mice were challenged with NP-BSA as 
described in Materials and Methods. DTH response was measured 24 h after challenge as 
the net footpad swelling. 
:~ See Table I. 
§ See Table I. 
II NGPS, normal guinea pig serum; anti-NP  b, guinea pig anti-NP  b idiotype; C, complement. 
Anti-Idiotype  Treatment of NP-induced Suppressor Cell Population.  Because of the appar- 
ent difference in specificity of suppression observed when mice were given suppressor 
cells on  the  day  of priming as  opposed  to  day of challenge, it  was  apparent  that 
different suppressor cell populations might be responsible for  the  two  phenomena. 
SJL mice were given 2  ×  107 NP-derivatized syngeneic spleen cells intravenously. 7 
d  later, these mice were sacrificed and 4  ×  107 suppressor cells were then transferred 
to recipients that  had been primed with NP-BGG 6  d  earlier, or to mice that  were 
primed after the cell transfer. Thus, the NP-SC population was given at  either the 
effector or induction phases of the immune response (Table III). Additional groups of 
mice received  these  suppressor cells after  in vitro treatment with  guinea pig anti- 
idiotype (anti-NP~ or normal guinea pig serum plus complement. The anti-idiotype 
used was raised by immunization of a  guinea pig with a  pool of specifically purified 
C57BL/6  primary  anti-NP  antibodies.  The  characterization  of  this  antiserum  is 
described in Materials and Methods. The anti-idiotype-treated  NP-induced suppressor 
cell populations lost the ability to suppress the afferent mode of the NP-primed, NP- 
elicited  DTH  response.  The  same  treated  cell  population,  however,  retained  the 
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on the day of challenge. Thus, the differential susceptibility of the effector suppressor 
to anti-idiotype plus complement define a  second  NP-specific "Is population  in  the 
original splenic population. 
H-2 Restriction  of Transfer  of NP-Specific Effector Suppression.  To investigate the role 
of the  MHC  in  the  ability  to  transfer  NP-specific  effector suppression,  allogeneic 
transfer experiments were performed with a series of H-2 congenic mice (Table IV). 
B10  and  4R  donors  of effector suppressor  cells  could  transfer  NP-specific  effector 
suppression into H-2-identical hosts; however, they would not transfer suppression to 
strains that differed from the donor strain at the I-A region of the H-2 complex (Table 
IV).  The  inability  to  transfer suppression  allogeneically  was  not  a  result  of acute 
rejection by the recipients, because (B6 X C3H)F1 effector suppressors were operative 
in a B10 host. 
To determine the critical subregions required  for transfer, 4R effector suppressors 
were transferred into B10.AQR.  The latter strain shares H-2 homology with the 4R 
donor  strain  only  at  the  I-A subregion  of the  H-2  complex.  Significant  levels  of 
suppression  were  transferred  between  these  strains.  Thus,  I-A  homology  alone  is 
sufficient  for  transfer  of  NP-specific  effector  suppression.  All  the  other  data  are 
consistent with this hypothesis. 
Allotype-linked Restriction on Transfer of NP-Specific Effector Suppression.  While perform- 
ing  the  above experiments,  we  had  several  indications  that  the  ability  to  transfer 
effector suppressor cells was not solely controlled by the H-2 complex. Thus, we noted 
that it was not possible to transfer NP effector suppressor cells between H-2-identical 
strains that differed in their non-H-2 background. The data in Table V  demonstrate 
that genes in the Igh-V region can also restrict the ability to transfer NP-SC. 
NP-specific effector suppressors were transferred between the BALB/c and C.B-20 
strains,  on  the  day of challenge  for an  NP-specific  DTH  response.  As  indicated  in 
Table V,  the  BALB/c  NP  effector suppressors  did  not  have an  effect  on  allotype 
congenic C.B-20 mice; similarly the C.B-20 suppressor population  did  not  suppress 
BALB/c hosts. This indicates that Igh genes control the ability of the NP effector Ts 
to  transfer  suppression.  The  BAB/14  strain  was  examined  because  it  carries  a 
recombinant  Igh allele  in  which  crossing-over occurred  between  the  Igh-C and  -V 
genetic  regions.  This  strain  has  the  Igh-C  allele  of C.B-20  and  the  Igh-V  region 
TABLE IV 





(K,A,B,J,E,C,S,D)  BI0  BI0  4R  4R  (B6 X C3H)FL 
C3tl)F~ 
control  NP-SC:~  control  NP-SC  control 
NP SC: 
BI0  bbbbbbbb  40.0 ±  1.8  I 1.4 2: 27§ 
4R  kkbbbbbb  40.4 ±  6.9  38.6 ±  77 
5R  bbbkkddd  40 7 ±  29  17.3 ±  3.8§ 
3R  bbbbkddd  43,3 ±  2.0  18.5  ±  28§ 
BI0.GD  ddbbbbbb  413 2:2.4  398 ±  2{} 
B 10.A  kkkkkddd 
B 10.A•R  qkkkkddd 
6R  qqqqqqqd 
5(14  ±  :]2  52.0 ±  4.6  46.3 ±  25  17 3 ±  2 7§ 
43 3 2:3 9  3 9  2: 36§ 
19.3 ±  37  12.8 4-  1.7 
51.2 ±  79  2{)3 2: 6.3§ 
413 4- 26  44.3 2= 4.!} 
* See Table 1. 
{ See Table  I. 
§ See "Fable  I. JUDAH Z.  WEINBERGER, BARUJ BENACERRAF, AND MARTIN E.  DORF 
TABLE V 
Transfer of Effector Suppression is Restricted by Igh-V Genes* 
Recipient  Cells transferred  NP DTH response 
C.B-20  Control  41.7 ± 2.4 
BALB/c NP-SC:~  41.3 + 5.0 
C.B-20 NP-SC  7.1 ± 3.4§ 
BALB/c  Control  39.4 + 2.8 
BALB/c NP-SC  14.2 ± 4.6~ 
C.B-20 NP-SC  44.1 ± 4.9 
BAB/14  Control  48.2 ± 3.3 
BALB/c NP-SC  12.8 ±  1.0~ 
C.B.-20 NP-SC  42.0 ± 5.2 
BALB.B  Control  38.2 ± 1.6 
BALB/e NP-SC  41.7 + 0.9 
C.B-20 NP-SG  36.2 ± 4.0 
* See Table I. 
:~ See Table I. 
§ See Table I. 
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(controlling anti-NP responses) of BALB/c. BALB/c suppressors could suppress BAB/ 
14  NP-specific DTH responses.  Thus,  Igh-C homology is  not  required,  and  Igh-V 
homology is sufficient  for elicitation of the suppressive effects. When C.B-20 strain 
suppressors were transferred to BAB/14, no significant suppression was observed. This 
indicates that Igh-C homology alone is insufficient for the transfer of effector-phase 
suppressor cells.  Taken together, these experiments indicate that an Igh-V match is 
required between the donor and recipient to obtain effector suppression. 
To establish that the ability to transfer NP effector suppressor cells is restricted by 
both  Igh-V and  MHC  genes,  we  tested  the  ability of BALB/c NP-SC  to  transfer 
suppression to the BALB.B strain, which shares common Igh alleles but differs at the 
H-2 complex. As shown in Table V, we could not transfer NP effector suppressor cells 
in this combination. Thus, for the successful transfer of effector suppressor cells there 
must be donor-host compatibility for both MHC and Igh-V genes. 
Discussion 
The experiments described demonstrate the ability of intravenously administered 
NP-derivatized syngeneic spleen cells to induce a population of NP-specific Ts capable 
of mediating suppression when given to previously primed animals (Tables I and II). 
Because of this capability, such "Is are termed effector-phase Ts, or, for simplicity, 
effector suppressors. The T  cell nature of this phenomenon was demonstrated, i.e., T 
cells were shown to be both necessary and sufficient to mediate such suppression. The 
existence of  effector-phase Ts active on cell-mediated immune responses was previously 
demonstrated in the DNP contact-sensitivity system (10).  Furthermore, Asherson et 
al. (11,  12) reported that a T cell-derived factor could be obtained from mice given an 
intravenous  injection  of picryl  sulfonic  acid;  this  factor,  when  cotransferred  with 
lymphocytes from mice primed with picryl chloride, suppressed the transfer of contact 
sensitivity. The observations herein extend the phenomenon to another, distinct cell- 
mediated immune response-DTH to haptenic determinants on soluble protein car- 
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The specificity of the NP effector Ts contrasts with that found for the suppression 
produced  by transfer of the suppressive populations  before priming.  To distinguish 
the  two  protocols,  and,  as  will  be  argued  below,  the  two  cells  involved,  we  have 
termed these,  respectively, induction-phase  and effector-phase suppressors.  The NP 
induction-phase  suppressors in  C57BL/6  mice were shown  to suppress NIP-primed 
responses with greater efficiency than even NP-primed responses (1).  In contrast, NP 
effector-phase suppression  in  C57BL/6  mice was only weakly cross-reactive on  the 
NIP-primed DTH response. 
The  difference in  the  specificity of suppression  noted  in  the  NP  induction-  and 
effector-phase suppressors led  us to search  for a  phenotypic  difference between  the 
cells.  The differential susceptibility of the induction  and effector suppressors to anti- 
idiotype  plus  complement  treatment  indicated  that  the  two  modes  of suppression 
involved distinct  T  cells.  Furthermore,  preliminary experiments indicate  that  these 
two cells are physically separable on  the basis of their antigen  or idiotype binding 
specificity. Thus, the inducer suppressor cell bears an idiotypic receptor, whereas the 
effector  suppressor  cell  apparently  bears  an  anti-idiotypic  receptor.  It  should  be 
emphasized that  these two cell populations  are simultaneously present  in  the same 
animal. 
The involvement of two T  cells in the suppression of immune responses has been 
demonstrated  for several other systems. Waltenbaugh  et  al.  (13)  first  demonstrated 
the ability of a  suppressor factor derived  from T  cells,  TsF, to  induce  polypeptide- 
specific Ts, termed T82. The distinctiveness of these two cells was convincingly shown 
by demonstration of strains capable of making T82 with exogenous TsF, but themselves 
unable to produce T~F or T~2. This has been confirmed  in  the  azobenzenearsonate 
system (14).  Another example of a  muhicellular pathway that  effects suppression  is 
the model proposed by Eardley et al. (15,  16) ofT cell-dependent feedback suppression 
of an ongoing immune response. These investigators showed that in an in vitro anti- 
erythrocyte response, an Ly-1  +, I-J  +, Qa-1 + T  cell acted upon an Ly-1+,2,3  +, I-J  +, Q a- 
1  + T  cell leading to production of an Ly-23  + Ts, which itself could dampen both the 
Ly-1 +,  I-J  +  inducer  and  the  Ly-1  +,  I-J-  helper  T  cell  activity.  The  relationship 
between  the  NP-induced,  inducer  and  effector Ts  has  not  been  addressed  in  the 
studies reported here. 
The presence of both  the effector and  inducer Ts populations  in  spleens  derived 
from  mice given  NP-derivatized  syngeneic  cells  raises  an  interesting  question,  i.e., 
whether the effector Ts can operate in the absence of the inducer Ts, or if purified 
effector suppressors active at the time of antigen priming might display a  phenotyp- 
ically  different  specificity  than  the  same  cells  transferred  to  an  already  primed 
recipient.  That the latter may indeed  by the case was suggested by the experiments 
shown in Table V. These experiments demonstrate that Igh-V homology is required 
between donor and recipient for efficient operation of NP-effector Ts. Because of the 
lack  of detectable  idiotype  on  the  effector Ts  (Table  III), a  reasonable  and  likely 
hypothesis is that the NP effector Ts recognizes the Igh-V gene product expressed by 
the TDTH or some other T  cell critical in expression of DTH, i.e.,  the receptor on the 
NP effector Ts is anti-idiotypic in  nature.  These findings are in  agreement with  the 
data of Owen et al.  (17),  Bona and Paul  (18),  and Sy et al.  (14), who demonstrated 
that  Ts  can  express  anti-idiotypic  receptors.  Preliminary  experiments  alluded  to 
earlier suggest that this is also the case for NP effector suppressor cells.  This provides JUDAH Z. WEINBERGER, BARUJ BENACERRAF, AND MARTIN E. DORF  1421 
strong genetic support for basic assumptions of network theories (19).  The feedback 
loop described by Eardley et al.  (16)  also shows Igh-V restriction at the level of the 
Ly-1  ÷, I-J  +, Qa-1 + suppressor inducer interaction with the Ly-1+,2,3  + intermediate T 
cell. 
The data in Tables IV and V  also demonstrate that the NP effector suppressor is 
also H-2 restricted. Mapping of the required subregion indicates that I-A homology 
is ~ufficient for transfer of suppression,  in the absence of other non-H-2 homology. 
The sufficiency of K-end homology could not be determined with the strains of mice 
available.  Miller  (20)  recently  reported  a  D-end  restriction  on  the  function  of 
suppressor in  contact sensitivity to dinitrofluorobenzene. Aside  from these  reports, 
MHC  restriction  in  the  pathway  to  suppression  of immune  responses  has  been 
investigated at the level of various Ts-derived factors (21, 22). It may be argued that 
these latter situations are not analogous to the one investigated here in that  MHC 
restriction may involve restriction on the activation of factor production or the ability 
to accept such factors. 
Whether the observed MHC  restriction is mediated by the same cell in  the NP 
effector suppressor populations, which  is also Igh-V  restricted, or if this represents 
another level of subset specificity mediated by different cells cannot be determined 
from experiments done thusfar.  Teleologically, it would seem  more likely that  the 
same  cell  would  mediate  both  effects.  A  simultaneous  MHC  and  receptor-anti- 
receptor recognition would add another level of complexity to the posulated network 
of lymphocyte interactions mediating immune responses and regulation. 
Summary 
4-Hydroxy-3-nitrophenyl acetyl  (NP)-derivatized syngeneic spleen cells adminis- 
tered intravenously induced a  population of suppressor T  cells that  could suppress 
mice previously primed to NP. The effect was demonstrable when the suppressor cells 
were  transferred  to  NP-primed  mice  on  the  day  of challenge  for  delayed-type 
hypersensitivity (DTH)  responses.  In contrast  to the suppressor T  cell population, 
which abrogates 5-iodo derivative of NP (NIP)-specific DTH responses when admin- 
istered  before  antigen  priming,  the  effector-phase suppressors  did  not  efficiently 
suppress NIP-specific DTH responses, and  were not  lysed by treatment  with  anti- 
idiotype plus complement. Adoptive transfer experiments between major histocom- 
patibility complex and allotype congenic strains of mice allowed demonstration of 
both Igh-V and I-A restrictions in the transfer of this cell population. The implications 
of these data in terms of network theories and proposed cellular models for negative 
immunoregulation were discussed. 
Received  for publication 30January  1980. 
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